163 results on '"Bauchau, Vincent"'
Search Results
2. Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
3. Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
4. Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines
5. The Brighton collaboration standardized module for vaccine benefit-risk assessment
6. Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view
7. The ADVANCE Code of Conduct for collaborative vaccine studies
8. Survival of Spoonbills on Wadden Sea Islands
9. Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt
10. Emergence and Reductionism: from the Game of Life to Science of Life
11. Is There a "File Drawer Problem" in Biological Research?
12. Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV—Priorix-Tetra™) Compared to Separate MMR + V Vaccination
13. Use of Logistic Regression to Combine Two Causality Criteria for Signal Detection in Vaccine Spontaneous Report Data
14. Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines†
15. Post-marketing monitoring of intussusception after rotavirus vaccination in Japan†
16. Comparison of parasitism level in two sympatric passerines: The pied flycatcher and the great tit
17. Opportunities and challenges for near real time monitoring (NRTM) of vaccine exposures and outcomes in the participating databases of the ADVANCE consortium
18. Signal detection based on time-to-onset: extending a new method from spontaneous reports to observational studies
19. The upper bound to the Relative Reporting Ratio—a measure of the impact of the violation of hidden assumptions underlying some disproportionality methods used in signal detection
20. Signal detection on spontaneous reports of adverse events following immunisation: a comparison of the performance of a disproportionality-based algorithm and a time-to-onset-based algorithm
21. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data?:An example using pertussis vaccination
22. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling
23. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases
24. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination
25. Optimization of a quantitative signal detection algorithm for spontaneous reports of adverse events post immunization
26. Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study
27. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling
28. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines
29. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination
30. Clutch desertion and re-nesting in pied flycatchers: an experiment with progressive clutch removal
31. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project
32. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project
33. Reduced trappability in wild mice, Mus musculus domesticus, heterozygous for Robertsonian translocations
34. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation – A contribution of the ADVANCE-project
35. Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe
36. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
37. Tree-based scan statistic – Application in manufacturing-related safety signal detection
38. Thomas Breuer and colleagues at GlaxoSmithKline respond to Peter Doshi
39. Benefit–Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project
40. Methodology for computing the burden of disease of adverse events following immunization
41. Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy
42. Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
43. Pandemrix™ and narcolepsy: A critical appraisal of the observational studies
44. Emergence and Reductionism: from the Game of Life to Science of Life
45. Signal detection on spontaneous reports of adverse events following immunisation: a comparison of the performance of a disproportionality‐based algorithm and a time‐to‐onset‐based algorithm
46. Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study
47. Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy.
48. Pandemrix™ and narcolepsy: A critical appraisal of the observational studies.
49. Optimization of a quantitative signal detection algorithm for spontaneous reports of adverse events post immunization
50. Anaphylaxis following H1N1 pandemic vaccines: Safety data in perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.